Academic detailing to improve laboratory testing among outpatient medication users

Medical Care

Volumn 45, Issue 10, 2007, Pages 966-972

  Lafata, Jennifer Eiston ^a   Gunter, Margaret J ^b   Hsu, John ^c   Kaatz, Scott ^a   Krajenta, Richard ^a   Platt, Richard ^d   Schultz, Lonni ^a   Selby, Joseph V ^c   Simon, Steven R ^d   Simpkins, Jan ^a   Soumerai, Stephen B ^d   Uratsu, Connie ^c  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b LOVELACE CLINIC FOUNDATION   (United States)

^c DIVISION OF RESEARCH   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Academic detailing; Medication safety; Physician practice patterns; Quality improvement

Indexed keywords

EID: 34748859763     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLR.0b013e3180546856     Document Type: Article

References (32)

1. Kohn LT, Corrigan JM, Donaldson MS. To Err Is Human: Building a Safer Health System. Washington, DC: Institute of Medicine and National Academy Press; 2000.
2. Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348:1556-1564.
3. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289:1107-1116.
4. Peng CC, Glassman PA, Marks IR, et al. Retrospective drug utilization review: incidence of clinically relevant potential drug-drug interactions in a large ambulatory population. J Manag Care Pharm. 2003;9:513-522.
5. Solberg LI, Hurley JS, Roberts MH, et al. Measuring patient safety in ambulatory care: potential for identifying medical group drug-drug interaction rates using claims data. Am J Manag Care. 2004;10(11, Pt 1):753-759.
6. Elston Lafata J, Schultz L, Simpkins J, et al. Potential drug-drug interactions in the outpatient setting. Med Care. 2006;44:534-541.
7. Lasser KE, Seger DL, Yu DT, et al. Adherence to black box warnings for prescription medications in outpatients. Arch Intern Med. 2006;166:338-344.
8. Raebel MA, Lyons EE, Andrade SE, et al. Laboratory monitoring of drugs at initiation of therapy in ambulatory care. J Gen Intern Med. 2005;20:1120-1126.
9. Simon SR, Andrade SE, Ellis JL, et al. Baseline laboratory monitoring of cardiovascular medications in elderly health maintenance organization enrollees. J Am Geriatr Soc. 2005;53:2165-2169.
10. Raebel MA, Carroll NM, Andrade SE, et al. Monitoring of drugs with a narrow therapeutic range in ambulatory care. Am J Manag Care. 2006;12:268-274.
11. Raebel MA, Carroll NM, Simon SR, et al. Liver and thyroid monitoring in ambulatory patients prescribed amiodarone in 10 HMOs. J Manag Care Pharm. 2006;12:656-664.
12. Raebel MA, McClure DL, Simon SR, et al. Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers. Pharmacoepidemiol Drug Saf. 2007;16:55-64.
13. O'Brien MA, Oxman AD, Davis DA, et al. Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database of Systematic. Reviews. 1997, Issue 4, Art. No. CD000409.
14. Diwan VK, Wahlstrom R, Tomson G, et al. Effects of "group detailing" on the prescribing of lipid-lowering drugs: a randomized controlled trial in Swedish primary care. J Clin Epidemiol. 1995;48:705-711.
15. Santoso B, Suryawati S, Prawaitasari JE. Small group intervention vs formal seminar for improving appropriate drug use. Soc. Sci Med. 1996;42:1163-1168.
16. Lundborg CS, Wahlstrom R, Oke T, et al. Influencing prescribing for urinary tract infection and asthma in primary care in Sweden: a randomized controlled trial of an interactive educational intervention. J Clin Epidemiol. 1999;52:801-812.
17. Figueiras A, Sastre I, Tato F, et al. One-to-one versus group sessions to improve prescription in primary care: a pragmatic randomized controlled trial. Med Care. 2001;39:158-167.
18. van Eijk ME, Avorn J, Porsius AJ, et al. Reducing prescribing of highly anticholinergic antidepressants for elderly people: randomised trial of group versus individual academic detailing. BMJ. 2001;322:654-657.
19. for the HMO Research Network CERTs Patient Safety Study Investigators. Chan KA, Development of a multipurpose dataset to evaluate potential medication errors in ambulatory settings. In: Henriksen K, Battles JB, Marks ES, et al, eds. Advances in Patient Safety: From Research to Implementation. Vol. 2, Concepts and Methodology. AHRQ Publication No. 05-0021-2, Rockville, MD: Agency for Healthcare Research and Quality; 2005:225-238.
20. Wu WK, Pantaleo N. Evaluation of outpatient adverse drug reactions leading to hospitalization. Am J Health Syst Pharm. 2003;60:253-259.
21. Soumerai SB, Avorn J. Principles of educational outreach (〈5001〉academic detailing') to improve clinical decision making. JAMA. 1990;263:549-556.
22. Smith DH, Perrin N, Feldstein A, et al. The impact of prescribing safety alerts for elderly persons in an electronic medical record: an interrupted time series evaluation. Arch Intern Med. 2006;166:1098-1104.
23. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
24. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2001;38:2101-2113.
25. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619.
26. Vine MF, Degnan D, Hanchette C. Geographic information systems: their use in environmental epidemiologic research. Environ Health Perspect. 1997;105:598-605.
27. Smith KM, McAdams JW, Frenia ML, et al. Drug-related problems in emergency department patients. Am J Health Syst Pharm. 1997;54:295-298.
28. Fick DM, Waller JL, Maclean JR, et al. Potentially inappropriate medication use in a Medicare managed care population: association with higher costs and utilization. J Manag Care Pharm. 2001;7:407-413.
29. Rodriguez-Monguio R, Otero MJ, Rovira J. Assessing the economic impact of adverse drug effects. Pharmacoeconomics. 2003;21:623-650.
30. Juurlink DN, Mamdani M, Kopp A, et al. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA. 2003;289:1652-1658.
31. Dormann H, Neubert A, Criegee-Rieck M, et al. Readmissions and adverse drug reactions in internal medicine: the economic impact. J Intern Med. 2004;255:653-663.
32. Feldstein AC, Smith DH, Perrin N, et al. Reducing warfarin medication interactions: an interrupted time series evaluation. Arch Intern Med. 2006;166:1009-1015.